Overview

Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease Patients

Status:
Completed

Trial end date:
2014-05-01

Target enrollment:

Participant gender:

Summary

The primary objective is to demonstrate that the Rotigotine transdermal patch is efficacious in Chinese subjects with early-stage idiopathic Parkinson's disease.

Phase:

Phase 3

Details

Lead Sponsor:

UCB Pharma

Treatments:

N 0437
Rotigotine